Hans Grasmuk

477 total citations
17 papers, 398 citations indexed

About

Hans Grasmuk is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Biotechnology. According to data from OpenAlex, Hans Grasmuk has authored 17 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 2 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Biotechnology. Recurrent topics in Hans Grasmuk's work include RNA and protein synthesis mechanisms (13 papers), RNA modifications and cancer (7 papers) and Chemical Synthesis and Analysis (5 papers). Hans Grasmuk is often cited by papers focused on RNA and protein synthesis mechanisms (13 papers), RNA modifications and cancer (7 papers) and Chemical Synthesis and Analysis (5 papers). Hans Grasmuk collaborates with scholars based in Austria, Germany and United States. Hans Grasmuk's co-authors include Jürgen Drews, Robert D. Nolan, Paul H. Ray, Frank M. Unger, Rudolf Weil, Ursula M. Rose, Reinhard Brossmer, Dennis L. Kasper, Gregor Högenauer and J. Drews and has published in prestigious journals such as Biochemical and Biophysical Research Communications, FEBS Letters and Journal of Bacteriology.

In The Last Decade

Hans Grasmuk

17 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans Grasmuk Austria 12 316 85 66 38 35 17 398
Annette M. C. Rapin United States 9 269 0.9× 55 0.6× 110 1.7× 25 0.7× 40 1.1× 13 410
Susan E. Carberry United States 12 334 1.1× 50 0.6× 30 0.5× 31 0.8× 68 1.9× 17 393
Robert D. Nolan Austria 13 275 0.9× 84 1.0× 18 0.3× 49 1.3× 35 1.0× 26 372
Daniel Kmiécik France 13 419 1.3× 61 0.7× 93 1.4× 22 0.6× 27 0.8× 18 522
K. Himmelspach Germany 12 255 0.8× 52 0.6× 97 1.5× 35 0.9× 75 2.1× 31 399
Willem M. Blanken Netherlands 10 404 1.3× 97 1.1× 246 3.7× 55 1.4× 39 1.1× 11 493
T. UKITA Japan 8 556 1.8× 113 1.3× 51 0.8× 66 1.7× 106 3.0× 14 668
Bo Ersson Sweden 12 346 1.1× 187 2.2× 63 1.0× 99 2.6× 66 1.9× 24 512
Johanna H. G. M. MUTSAERS Netherlands 13 457 1.4× 96 1.1× 234 3.5× 61 1.6× 68 1.9× 19 543
Kazuo Terao Japan 16 614 1.9× 98 1.2× 16 0.2× 20 0.5× 20 0.6× 38 667

Countries citing papers authored by Hans Grasmuk

Since Specialization
Citations

This map shows the geographic impact of Hans Grasmuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Grasmuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Grasmuk more than expected).

Fields of papers citing papers by Hans Grasmuk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Grasmuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Grasmuk. The network helps show where Hans Grasmuk may publish in the future.

Co-authorship network of co-authors of Hans Grasmuk

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Grasmuk. A scholar is included among the top collaborators of Hans Grasmuk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Grasmuk. Hans Grasmuk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ray, Paul H., et al.. (1981). Purification and characterization of cytidine 5'-triphosphate:cytidine 5'-monophosphate-3-deoxy-D-manno-octulosonate cytidylyltransferase.. Journal of Bacteriology. 145(3). 1273–1280. 46 indexed citations
2.
Brossmer, Reinhard, et al.. (1980). Enzymic synthesis of 5-acetamido-9-azido-3,5,9-trideoxy--glycero--galacto-2-nonulosonic acid, a 9-azido-9-deoxy derivative of N-acetylneuraminic acid. Biochemical and Biophysical Research Communications. 96(3). 1282–1289. 48 indexed citations
3.
Nolan, Robert D., Hans Grasmuk, & Jürgen Drews. (1979). [59] Preparation and elongation factors from ascites cells. Methods in enzymology on CD-ROM/Methods in enzymology. 60. 649–657. 6 indexed citations
4.
Grasmuk, Hans, Robert D. Nolan, & Jürgen Drews. (1978). The Isolation and Characterization of Elongation Factor eEF‐Ts from Krebs‐II Mouse‐Ascites‐Tumor Cells and Its Role in the Elongation Process. European Journal of Biochemistry. 92(2). 479–490. 15 indexed citations
5.
Grasmuk, Hans, Robert D. Nolan, & Jürgen Drews. (1977). Further Evidence that Elongation Factor 1 Remains Bound to Ribosomes during Peptide Chain Elongation. European Journal of Biochemistry. 79(1). 93–102. 22 indexed citations
6.
Grasmuk, Hans, Robert D. Nolan, & Jürgen Drews. (1977). Interchangeability of elongation factor‐Tu and elongation factor‐1 in aminoacyl‐tRNA binding to 70 S and 80 S ribosomes. FEBS Letters. 82(2). 237–242. 11 indexed citations
7.
Nolan, Robert D., Hans Grasmuk, & Jürgen Drews. (1976). The Binding of Tritiated Elongation‐Factors 1 and 2 to Ribosomes from Krebs II Mouse Ascites‐Tumor Cells. European Journal of Biochemistry. 64(1). 69–75. 35 indexed citations
8.
Grasmuk, Hans, Robert D. Nolan, & Jürgen Drews. (1976). A New Concept of the Function of Elongation Factor 1 in Peptide Chain Elongation. European Journal of Biochemistry. 71(1). 271–279. 22 indexed citations
9.
Grasmuk, Hans, Robert D. Nolan, & Jürgen Drews. (1976). Functional Identity of the Monomeric and Multiple Forms of Elongation‐Factor 1 from Krebs‐II Mouse‐Ascites‐Tumor Cells. European Journal of Biochemistry. 67(2). 421–431. 13 indexed citations
10.
Grasmuk, Hans, Robert D. Nolan, & Jürgen Drews. (1975). The stimulation of labelled polynucleotide binding to krebs II ascites and Escherichia coli ribosomes by deacylated tRNAs.. FEBS Letters. 53(2). 229–233. 8 indexed citations
11.
Nolan, Robert D., Hans Grasmuk, & Jürgen Drews. (1975). The Binding of Tritiated Elongation Factors 1 and 2 to Ribosomes from Krebs II Mouse Ascites Tumor Cells. European Journal of Biochemistry. 50(2). 391–402. 50 indexed citations
12.
Nolan, Robert D., Hans Grasmuk, Gregor Högenauer, & Jürgen Drews. (1974). Elongation Factor 1 from Krebs II Mouse Ascites Cells. Interaction with Guanosine Nucleotides and Aminoacyl-tRNA. European Journal of Biochemistry. 45(2). 601–609. 22 indexed citations
13.
Grasmuk, Hans, Robert D. Nolan, & Jürgen Drews. (1974). Elongation Factor 1 from Ascites Tumor Cells: Interaction with Ribosomes and Elongation Factor 2. European Journal of Biochemistry. 48(2). 485–493. 14 indexed citations
14.
Drews, Jürgen, et al.. (1974). Elongation Factor 1 from Krebs II Mouse Ascites Cells. European Journal of Biochemistry. 41(2). 217–227. 53 indexed citations
15.
Drews, J., Hans Grasmuk, & Frank M. Unger. (1973). Peptide chain initiation with chemically formylated Met-tRNAs from E. coli and yeast. Biochemical and Biophysical Research Communications. 51(3). 804–812. 7 indexed citations
16.
Drews, Jürgen, Hans Grasmuk, & Rudolf Weil. (1972). Utilization of Methionine‐Accepting tRNA Species from Escherichia coli, Ascites‐Tumor Cells, and Yeast in Homologous and Heterologous Cell‐Free Systems. European Journal of Biochemistry. 29(1). 119–127. 15 indexed citations
17.
Drews, Jürgen, Hans Grasmuk, & Rudolf Weil. (1972). Function of Met‐tRNAMetf and Met‐tRNAMet in Peptide‐Chain Elongation in Cell‐Free Systems from Mouse‐Liver and Ascites‐Tumor Cells. European Journal of Biochemistry. 26(3). 416–425. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annette M. C. Rapin Breakdown of academic impact, for papers by Susan E. Carberry Breakdown of academic impact, for papers by Robert D. Nolan Breakdown of academic impact, for papers by Daniel Kmiécik Breakdown of academic impact, for papers by K. Himmelspach Breakdown of academic impact, for papers by Willem M. Blanken Breakdown of academic impact, for papers by T. UKITA Breakdown of academic impact, for papers by Bo Ersson Breakdown of academic impact, for papers by Johanna H. G. M. MUTSAERS Breakdown of academic impact, for papers by Kazuo Terao
Rankless by CCL
2026